Identification of Novel MicroRNAs in Post-transcriptional Control of Nrf2 Expression and Redox Homeostasis in Neuronal, SH-SY5Y Cells
Overview
Authors
Affiliations
Nuclear factor-erythroid 2-related factor 2 (Nrf2/NFE2L2), a redox-sensitive transcription factor plays a critical role in adaptation to cellular stress and affords cellular defense by initiating transcription of antioxidative and detoxification genes. While a protein can be regulated at multiple levels, control of Nrf2 has been largely studied at post-translational regulation points by Keap1. Importantly, post-transcriptional/translational based regulation of Nrf2 is less understood and to date there are no reports on such mechanisms in neuronal systems. In this context, studies involving the role of microRNAs (miRs) which are normally considered as fine tuning regulators of protein production through translation repression and/or post-transcriptional alterations, are in place. In the current study, based on in-silico analysis followed by immunoblotting and real time analysis, we have identified and validated for the first time that human NFE2L2 could be targeted by miR153/miR27a/miR142-5p/miR144 in neuronal, SH-SY5Y cells. Co-transfection studies with individual miR mimics along with either WT 3' UTR of human Nrf2 or mutated miRNA targeting seed sequence within Nrf2 3' UTR, demonstrated that Nrf2 is a direct regulatory target of these miRs. In addition, ectopic expression of miR153/miR27a/miR142-5p/miR144 affected Nrf2 mRNA abundance and nucleo-cytoplasmic concentration of Nrf2 in a Keap1 independent manner resulting in inefficient transactivating ability of Nrf2. Furthermore, forced expression of miRs diminished GCLC and GSR expression resulting in alteration of Nrf2 dependent redox homeostasis. Finally, bioinformatics based miRNA-disease network analysis (MDN) along with extended computational network analysis of Nrf2 associated pathologic processes suggests that if in a particular cellular scenario where any of these miR153/miR27a/miR142-5p/miR144 either individually or as a group is altered, it could affect Nrf2 thus triggering and/or determining the fate of wide range of disease outcomes.
Moradi Vastegani Z, Ghaedi-Heidari R, Oroujalian A, Peymani M, Ghaedi K Metab Brain Dis. 2025; 40(3):141.
PMID: 40067516 DOI: 10.1007/s11011-025-01568-z.
The Role of miR-144 in Inflammatory Diseases: A Review.
Hong S, Wang H, Qiao L Immun Inflamm Dis. 2025; 13(3):e70172.
PMID: 40067024 PMC: 11894823. DOI: 10.1002/iid3.70172.
Mitochondria and its epigenetic dynamics: Insight into synaptic regulation and synaptopathies.
Gupta S, Kishore A, Rishi V, Aggarwal A Funct Integr Genomics. 2025; 25(1):26.
PMID: 39849126 DOI: 10.1007/s10142-025-01530-3.
Circulating MicroRNAs in Idiopathic Pulmonary Fibrosis: A Narrative Review.
Colin Waldo M, Quintero-Millan X, Negrete-Garcia M, Ruiz V, Sommer B, Romero-Rodriguez D Curr Issues Mol Biol. 2024; 46(12):13746-13766.
PMID: 39727949 PMC: 11674445. DOI: 10.3390/cimb46120821.
Nrf2 Signaling Pathway: Focus on Oxidative Stress in Spinal Cord Injury.
Xiao C, Lai H, Zhou J, Liu W, Zhao M, Zhao K Mol Neurobiol. 2024; 62(2):2230-2249.
PMID: 39093381 DOI: 10.1007/s12035-024-04394-z.